CPT Codes
CMS14,403
Total Codes
14,403
Active
0
Obsolete
0
With Definitions
CPT Codes Directory
14403 codes
| Code | Preferred Label | Status | Semantic Types | Details |
|---|---|---|---|---|
| 81439 |
Hereditary cardiomyopathy (eg, hypertrophic cardiomyopathy, dilated cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy), genomic sequence analysis panel, must include sequencing of at least 5 cardiomyopathy-related genes (eg, DSG2, MYBPC3, MYH7, PKP2, TTN)
Hereditary cardiomyopathy genomic sequence analysis panel, including DSG2, MYBPC3, MYH7, PKP2, and TTN; Hereditary cardiomyopathy genomic sequence analysis
+2 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81440 |
Nuclear encoded mitochondrial genes (eg, neurologic or myopathic phenotypes), genomic sequence panel, must include analysis of at least 100 genes, including BCS1L, C10orf2, COQ2, COX10, DGUOK, MPV17, OPA1, PDSS2, POLG, POLG2, RRM2B, SCO1, SCO2, SLC25A4, SUCLA2, SUCLG1, TAZ, TK2, and TYMP
NUCLEAR MITOCHONDRIAL 100 GENE GENOMIC SEQ; Test for detecting genes
+1 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81442 |
Noonan spectrum disorders (eg, Noonan syndrome, cardio-facio-cutaneous syndrome, Costello syndrome, LEOPARD syndrome, Noonan-like syndrome), genomic sequence analysis panel, must include sequencing of at least 12 genes, including BRAF, CBL, HRAS, KRAS, MAP2K1, MAP2K2, NRAS, PTPN11, RAF1, RIT1, SHOC2, and SOS1
Gene analysis (noonan syndrome) genomic sequence analysis; NOONAN SPECTRUM DISORDERS GEN SEQ ANALYS 12 GEN
+1 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81443 |
Genetic testing for severe inherited conditions (eg, cystic fibrosis, Ashkenazi Jewish-associated disorders [eg, Bloom syndrome, Canavan disease, Fanconi anemia type C, mucolipidosis type VI, Gaucher disease, Tay-Sachs disease], beta hemoglobinopathies, phenylketonuria, galactosemia), genomic sequence analysis panel, must include sequencing of at least 15 genes (eg, ACADM, ARSA, ASPA, ATP7B, BCKDHA, BCKDHB, BLM, CFTR, DHCR7, FANCC, G6PC, GAA, GALT, GBA, GBE1, HBB, HEXA, IKBKAP, MCOLN1, PAH)
GENETIC TESTING FOR SEVERE INHERITED CONDITIONS; Genomic sequence analysis of 15 or more genes for detection of severe inherited conditions
+1 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81445 |
Targeted genomic sequence analysis panel, solid organ neoplasm, DNA analysis, and RNA analysis when performed, 5-50 genes (eg, ALK, BRAF, CDKN2A, EGFR, ERBB2, KIT, KRAS, NRAS, MET, PDGFRA, PDGFRB, PGR, PIK3CA, PTEN, RET), interrogation for sequence variants and copy number variants or rearrangements, if performed
Test for detecting genes associated with cancer of body organ; Solid organ neoplasm genomic sequence analysis panel with DNA analysis
+4 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81448 |
Hereditary peripheral neuropathies (eg, Charcot-Marie-Tooth, spastic paraplegia), genomic sequence analysis panel, must include sequencing of at least 5 peripheral neuropathy-related genes (eg, BSCL2, GJB1, MFN2, MPZ, REEP1, SPAST, SPG11, SPTLC1)
Hereditary peripheral neuropathies panel genomic sequence analysis; Gene analysis panel for hereditary disorders of the peripheral nervous system
+1 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81450 |
Targeted genomic sequence analysis panel, hematolymphoid neoplasm or disorder, DNA analysis, and RNA analysis when performed, 5-50 genes (eg, BRAF, CEBPA, DNMT3A, EZH2, FLT3, IDH1, IDH2, JAK2, KRAS, KIT, MLL, NRAS, NPM1, NOTCH1), interrogation for sequence variants, and copy number variants or rearrangements, or isoform expression or mRNA expression levels, if performed
Hematolymphoid disorder genomic sequence analysis panel with RNA analysis; GEN SEQ ANALYS HEMATOLYMPHOID NEO 5-50 GENE
+4 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81455 |
Targeted genomic sequence analysis panel, solid organ or hematolymphoid neoplasm, DNA analysis, and RNA analysis when performed, 51 or greater genes (eg, ALK, BRAF, CDKN2A, CEBPA, DNMT3A, EGFR, ERBB2, EZH2, FLT3, IDH1, IDH2, JAK2, KIT, KRAS, MLL, NPM1, NRAS, MET, NOTCH1, PDGFRA, PDGFRB, PGR, PIK3CA, PTEN, RET), interrogation for sequence variants and copy number variants or rearrangements, if performed
Solid organ neoplasm genomic sequence analysis panel; Hematolymphoid neoplasm genomic sequence analysis panel with DNA analysis
+4 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81460 |
Whole mitochondrial genome (eg, Leigh syndrome, mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes [MELAS], myoclonic epilepsy with ragged-red fibers [MERFF], neuropathy, ataxia, and retinitis pigmentosa [NARP], Leber hereditary optic neuropathy [LHON]), genomic sequence, must include sequence analysis of entire mitochondrial genome with heteroplasmy detection
Test for detecting genes associated with disease; Mitochondrially encoded genomic sequence analysis with detection of heteroplasmy
+1 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81465 |
Whole mitochondrial genome large deletion analysis panel (eg, Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia), including heteroplasmy detection, if performed
Mitochondrially encoded genomic sequence analysis for detection of deletion and heteroplasmy variants; Mitochondrially encoded genomic sequence analysis for detection of deletion variants
+2 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81470 |
X-linked intellectual disability (XLID) (eg, syndromic and non-syndromic XLID); genomic sequence analysis panel, must include sequencing of at least 60 genes, including ARX, ATRX, CDKL5, FGD1, FMR1, HUWE1, IL1RAPL, KDM5C, L1CAM, MECP2, MED12, MID1, OCRL, RPS6KA3, and SLC16A2
Test for detecting genes associated with intellectual disability; X-LINKED INTELLECTUAL DBLT GENOMIC SEQ ANALYS
+1 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81471 |
X-linked intellectual disability (XLID) (eg, syndromic and non-syndromic XLID); duplication/deletion gene analysis, must include analysis of at least 60 genes, including ARX, ATRX, CDKL5, FGD1, FMR1, HUWE1, IL1RAPL, KDM5C, L1CAM, MECP2, MED12, MID1, OCRL, RPS6KA3, and SLC16A2
Test for detecting genes associated with intellectual disability; X-LINKED INTELLECTUAL DBLT DUP/DEL GENE ANALYS
+1 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81479 |
Unlisted molecular pathology procedure
UNLISTED MOLECULAR PATHOLOGY PROCEDURE; Molecular pathology procedure
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81490 |
Autoimmune (rheumatoid arthritis), analysis of 12 biomarkers using immunoassays, utilizing serum, prognostic algorithm reported as a disease activity score
Analysis of biomarkers using immunoassay for autoimmune arthritis; Test for detecting genes associated with rheumatoid arthritis using immunoassay technique
+1 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81493 |
Coronary artery disease, mRNA, gene expression profiling by real-time RT-PCR of 23 genes, utilizing whole peripheral blood, algorithm reported as a risk score
Coronary artery disease (mRNA) gene expression analysis by real-time PCR of 23 genes; COR ART DISEASE MRNA GENE EXPRESSION 23 GENES
+1 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81500 |
Oncology (ovarian), biochemical assays of two proteins (CA-125 and HE4), utilizing serum, with menopausal status, algorithm reported as a risk score
Biochemical assay of two proteins including CA-125 and HE4 utilizing serum for ovarian cancer; ONCO (OVARIAN) BIOCHEMICAL ASSAY TWO PROTEINS
+1 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81503 |
Oncology (ovarian), biochemical assays of five proteins (CA-125, apolipoprotein A1, beta-2 microglobulin, transferrin, and pre-albumin), utilizing serum, algorithm reported as a risk score
Biochemical assay of five proteins including CA-125, apolipoprotein, beta-2 microglobulin, transferrin and prealbumin utilizing serum for ovarian cancer; ONCO (OVARIAN) BIOCHEMICAL ASSAY FIVE PROTEINS
+1 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81504 |
Oncology (tissue of origin), microarray gene expression profiling of > 2000 genes, utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as tissue similarity scores
Gene profiling using microarray gene expression; ONCOLOGY TISSUE OF ORIGIN SIMILAR SCOR ALGORITHM
+1 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81506 |
Endocrinology (type 2 diabetes), biochemical assays of seven analytes (glucose, HbA1c, insulin, hs-CRP, adiponectin, ferritin, interleukin 2-receptor alpha), utilizing serum or plasma, algorithm reporting a risk score
Biochemical assay of seven analytes including glucose, HbA1c, insulin, hs-CRP, adiponectin, ferritin and interleukin 2 - receptor alpha utilizing plasma; ENDOCRINOLOGY BIOCHEMICAL ASSAY SEVEN ANAL
+2 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81507 |
Fetal aneuploidy (trisomy 21, 18, and 13) DNA sequence analysis of selected regions using maternal plasma, algorithm reported as a risk score for each trisomy
Biochemical assay of chromosome 21, 18 and 13 utilizing maternal plasma for fetal aneuploidy; DNA analysis using maternal plasma
+1 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81508 |
Fetal congenital abnormalities, biochemical assays of two proteins (PAPP-A, hCG [any form]), utilizing maternal serum, algorithm reported as a risk score
FETAL CONGENITAL ABNOR ASSAY TWO PROTEINS; Fetal congenital abnormalities, biochemical assays of two proteins (papp-a, hcg [any form]), utilizing maternal serum, algorithm reported as a risk score
+1 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81509 |
Fetal congenital abnormalities, biochemical assays of three proteins (PAPP-A, hCG [any form], DIA), utilizing maternal serum, algorithm reported as a risk score
Biochemical assay of three proteins including PAPP-A, hCG and DIA utilizing maternal serum for fetal congenital abnormality; FETAL CONGENITAL ABNOR ASSAY 3 PROTEINS
+1 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81510 |
Fetal congenital abnormalities, biochemical assays of three analytes (AFP, uE3, hCG [any form]), utilizing maternal serum, algorithm reported as a risk score
Fetal congenital abnormalities, biochemical assays of three analytes (afp, ue3, hcg [any form]), utilizing maternal serum, algorithm reported as a risk score; Biochemical assay of three analytes including AFP, uE3 and hCG utilizing maternal serum for fetal congenital abnormality
+1 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81511 |
Fetal congenital abnormalities, biochemical assays of four analytes (AFP, uE3, hCG [any form], DIA) utilizing maternal serum, algorithm reported as a risk score (may include additional results from previous biochemical testing)
Biochemical assay of four analytes including AFP, uE3, hCG and DIA utilizing maternal serum for fetal congenital abnormality; Fetal congenital abnormalities, biochemical assays of four analytes (afp, ue3, hcg [any form], dia) utilizing maternal serum, algorithm reported as a risk score
+1 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81512 |
Fetal congenital abnormalities, biochemical assays of five analytes (AFP, uE3, total hCG, hyperglycosylated hCG, DIA) utilizing maternal serum, algorithm reported as a risk score
Biochemical assay of five analytes including AFP, uE3, total hCG, hyperglycosylated hCG and DIA utilizing maternal serum for fetal congenital abnormality; FETAL CONGENITAL ABNOR ASSAY FIVE ANAL
+1 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81518 |
Oncology (breast), mRNA, gene expression profiling by real-time RT-PCR of 11 genes (7 content and 4 housekeeping), utilizing formalin-fixed paraffin-embedded tissue, algorithms reported as percentage risk for metastatic recurrence and likelihood of benefit from extended endocrine therapy
mRNA gene analysis of 11 genes in breast tumor tissue; ONCOLOGY BREAST MRNA GENE EXPRESSION 11 GENES
+1 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81519 |
Oncology (breast), mRNA, gene expression profiling by real-time RT-PCR of 21 genes, utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as recurrence score
Test for detecting genes associated with breast cancer; Breast cancer (mRNA) gene expression analysis by real-time PCR of 21 genes
+1 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81520 |
Oncology (breast), mRNA gene expression profiling by hybrid capture of 58 genes (50 content and 8 housekeeping), utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as a recurrence risk score
Breast cancer mRNA gene expression profiling by hybrid capture of 58 genes (50 content and 8 housekeeping), using formalin-fixed paraffin-embedded tissue, algorithm reported as a recurrence risk score; ONC BREAST MRNA GENE XPRSN PRFL HYBRD 58 GENES
+1 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81521 |
Oncology (breast), mRNA, microarray gene expression profiling of 70 content genes and 465 housekeeping genes, utilizing fresh frozen or formalin-fixed paraffin-embedded tissue, algorithm reported as index related to risk of distant metastasis
Breast cancer mRNA microarray gene expression profiling of 70 content genes and 465 housekeeping genes, utilizing fresh frozen tissue, algorithm reported as index related to risk of distant metastasis; Breast cancer mRNA microarray gene expression profiling of 70 content genes and 465 housekeeping genes
+3 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81522 |
Oncology (breast), mRNA, gene expression profiling by RT-PCR of 12 genes (8 content and 4 housekeeping), utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as recurrence risk score
mRNA gene expression analysis of 12 genes in breast tumor tissue; ONCOLOGY BREAST MRNA GENE XPRSN PRFL 12 GENES
+1 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81525 |
Oncology (colon), mRNA, gene expression profiling by real-time RT-PCR of 12 genes (7 content and 5 housekeeping), utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as a recurrence score
ONCOLOGY COLON MRNA GENE EXPRESSION 12 GENES; Colon cancer (mRNA) gene expression profiling by real-time PCR of 12 genes (7 content and 5 housekeeping)
+1 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81528 |
Oncology (colorectal) screening, quantitative real-time target and signal amplification of 10 DNA markers (KRAS mutations, promoter methylation of NDRG4 and BMP3) and fecal hemoglobin, utilizing stool, algorithm reported as a positive or negative result
ONCOLOGY COLORECTAL SCREENING QUAN 10 DNA MARKRS; Gene analysis (colorectal cancer)
+1 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81535 |
Oncology (gynecologic), live tumor cell culture and chemotherapeutic response by DAPI stain and morphology, predictive algorithm reported as a drug response score; first single drug or drug combination
Gynecologic live tumor cell culture and chemotherapeutic response by DAPI stain; Culture of live tumor cells and chemotherapy drug response by staining
+1 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81536 |
Oncology (gynecologic), live tumor cell culture and chemotherapeutic response by DAPI stain and morphology, predictive algorithm reported as a drug response score; each additional single drug or drug combination (List separately in addition to code for primary procedure)
ONCOLOGY GYNE LIVE TUM CELL CLTR&CHEMO RESP ADD; Gynecologic live tumor cell culture and chemotherapeutic response by DAPI stain
+1 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81538 |
Oncology (lung), mass spectrometric 8-protein signature, including amyloid A, utilizing serum, prognostic and predictive algorithm reported as good versus poor overall survival
ONCOLOGY LUNG MS 8-PROTEIN SIGNATURE; Testing of lung tumor cells for prediction of survival
+1 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81539 |
Oncology (high-grade prostate cancer), biochemical assay of four proteins (Total PSA, Free PSA, Intact PSA, and human kallikrein-2 [hK2]), utilizing plasma or serum, prognostic algorithm reported as a probability score
Biochemical assay of total PSA, free PSA, intact PSA, and human kallikrein-2 [hK2 in serum, with prognostic algorithm reported as a probability score; ONCOLOGY PROSTATE BIOCHEMICAL ASSAY 4 PROTEINS
+2 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81540 |
Oncology (tumor of unknown origin), mRNA, gene expression profiling by real-time RT-PCR of 92 genes (87 content and 5 housekeeping) to classify tumor into main cancer type and subtype, utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as a probability of a predicted main cancer type and subtype
ONCOLOGY TUM UNKNOWN ORIGIN MRNA 92 GENES; Gene analysis (cancer)
+1 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81541 |
Oncology (prostate), mRNA gene expression profiling by real-time RT-PCR of 46 genes (31 content and 15 housekeeping), utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as a disease-specific mortality risk score
Prostate cancer mRNA gene expression profiling by real-time RT-PCR of 46 genes (31 content and 15 housekeeping), utilizing formalin-fixed paraffin embedded tissue, algorithm reported as a disease-specific mortality risk score; Gene analysis of prostate tumor tissue
+1 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81542 |
Oncology (prostate), mRNA, microarray gene expression profiling of 22 content genes, utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as metastasis risk score
ONC PRST8 MRNA MICRORA GENE XPRSN PRFL 22 GENES; mRNA microarray gene expression profiling of 22 content genes in formalin-fixed paraffin-embedded tissue, algorithm reported as metastasis risk score
+1 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81545 |
Oncology (thyroid), gene expression analysis of 142 genes, utilizing fine needle aspirate, algorithm reported as a categorical result (eg, benign or suspicious)
ONCOLOGY THYROID GENE EXPRESSION 142 GENES; Thyroid cancer gene expression analysis of 142 genes
+1 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81551 |
Oncology (prostate), promoter methylation profiling by real-time PCR of 3 genes (GSTP1, APC, RASSF1), utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as a likelihood of prostate cancer detection on repeat biopsy
Prostate cancer mRNA gene expression profiling by real-time PCR of 3 genes (GSTP1, APC, RASSF1), utilizing formalin-fixed paraffin embedded tissue, algorithm reported as a likelihood of prostate cancer detection on repeat biopsy; Gene analysis of prostate tumor tissue
+1 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81552 |
Oncology (uveal melanoma), mRNA, gene expression profiling by real-time RT-PCR of 15 genes (12 content and 3 housekeeping), utilizing fine needle aspirate or formalin-fixed paraffin-embedded tissue, algorithm reported as risk of metastasis
mRNA gene expression analysis of 15 genes in eye melanoma o tissue or fine needle aspirate; mRNA gene expression profiling of uveal melanoma by real-time polymerase chain reaction (RT-PCR) of 15 genes (12 content and 3 housekeeping), in formalin-fixed paraffin-embedded tissue, algorithm reported as risk of metastasis
+2 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81595 |
Cardiology (heart transplant), mRNA, gene expression profiling by real-time quantitative PCR of 20 genes (11 content and 9 housekeeping), utilizing subfraction of peripheral blood, algorithm reported as a rejection risk score
Heart transplant (mRNA) gene expression profiling by real-time quantitative PCR of 20 genes; Test for detecting genes associated with heart diseases
+1 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81596 |
Infectious disease, chronic hepatitis C virus (HCV) infection, six biochemical assays (ALT, A2-macroglobulin, apolipoprotein A-1, total bilirubin, GGT, and haptoglobin) utilizing serum, prognostic algorithm reported as scores for fibrosis and necroinflammatory activity in liver
NFCT DS CHRNC HCV 6 BIOCHEM ASSAY SRM ALG LVR; Biochemical assays for evaluation of chronic Hepatitis C virus infection
+1 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 81599 |
Unlisted multianalyte assay with algorithmic analysis
Multianalyte assay procedure with algorithmic analysis; UNLISTED MULTIANALYTE ASSAY ALGORITHMIC ANALYSIS
+1 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 82 |
Assistant Surgeon (when qualified resident surgeon not available)
|
Active |
http://purl.bioontology.org/ontology/STY/T058
|
|
| 82009 |
Ketone body(s) (eg, acetone, acetoacetic acid, beta-hydroxybutyrate); qualitative
Qualitative analysis of ketone body in serum; Ketone bodies analysis
+2 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 82010 |
Ketone body(s) (eg, acetone, acetoacetic acid, beta-hydroxybutyrate); quantitative
Measurement of acetone in serum; Ketone bodies analysis
+2 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 82013 |
Acetylcholinesterase
Measurement of red blood cell acetylcholinesterase; Acetylcholinesterase (enzyme) level
+1 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|
|
| 82016 |
Acylcarnitines; qualitative, each specimen
ACYLCARNITINES QUALITATIVE EACH SPECIMEN; Chemical analysis for genetic disorder
+1 more
|
Active |
http://purl.bioontology.org/ontology/STY/T059
|